Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 21

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 21
---
, San Jose, CA 95133, and our telephone number at that address is (833) 534-3623. Our website is available at www.wearelegence.com. We expect to make our
periodic reports and other information filed with or furnished to the SEC available free of charge through our website as soon as reasonably practicable after those reports and other information are electronically filed with or furnished to the SEC.
Information on our website or any other website is not incorporated by reference herein and does not constitute a part of this prospectus.

9

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83

The Offering

| Class A Common Stock offered by us | shares (or      shares, if the underwriters exercise in full their option to purchase additional shares). |

| Option to purchase additional shares | We and the selling stockholder have granted the underwriters a 30-day option to purchase up to      additional shares of our Class A Common Stock from us and 
 additional shares of Class A Common Stock from the selling stockholder.                                                                                       |

| Class A Common Stock to be outstanding after the offering | shares (or      shares, if the underwriters exercise in full their option to purchase additional shares). |

| Class B Common Stock to be outstanding immediately after completion of this offering | shares (or      shares, if the underwriters exercise in full their option to purchase additional shares and after giving effect to the application of the net proceeds therefrom), or one share 
 for each LGN Unit held by the LGN Unit Holders immediately following this offering. Class B Common Stock is non-economic. When a LGN Unit is exchanged for a share of Class A Common Stock, a   
 corresponding share of Class B Common Stock will be surrendered.                                                                                                                                |

| Use of proceeds | We expect to receive approximately $   million of net proceeds from the sale of the Class A Common Stock offered by us (assuming no exercise of the underwriters’ option to purchase additional shares), assuming an initial                            
 public offering price of $   per share, which is the midpoint of the price range on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. A $1.00 increase           
 (decrease) in the assumed initial public offering price of